NDC 63402-681-01 - UTIBRON NEOHALER
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63402-681
- Requested NDC
- 63402-681-01
- Package NDCs from labels
- 63402-681-01, 63402-681-60, 63402-681-06, 63402-681-02, 63402-681-12
- Manufacturer
- Sunovion Pharmaceuticals Inc.
- Effective date
- 2019-05-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| UTIBRON NEOHALER - Sunovion Pharmaceuticals Inc. | Sunovion Pharmaceuticals Inc. | 2019-05-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63402-681-01 | EA - Each | 63402-681 | fdf9a6c3-5389-43b6-b079-50d744dc12f6 | 1 | 2018-04-19 |
| 63402-681-06 | EA - Each | 63402-681 | 9eef7d49-3376-4482-b546-cd4a99897904 | 1 | 2018-04-19 |
| 63402-681-60 | EA - Each | 63402-681 | c91b1e50-982d-4197-8a4c-105b40d16fab | 1 | 2018-06-11 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| GLYCOPYRROLATE | GLYCOPYRROLATE | QUAGEN PHARMACEUTICALS LLC | 62e1ba35-bc84-4818-be54-8b534a1bf93c | 2026-09-10 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Bryant Ranch Prepack | f7187ddb-ea11-4aa8-8215-a5fcf0f1ca7c | 2026-09-09 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Henry Schein, Inc. | 4ecb3435-58e5-46cb-b8c2-85b5fd955f83 | 2026-09-09 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Par Health USA, LLC | 1f266d77-4f9e-44c9-a000-2f8fea3ac80b | 2026-07-09 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Amneal Pharmaceuticals LLC | bbab4cf1-0441-4fc4-9de9-e4117fa19faa | 2026-07-07 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Piramal Critical Care Inc | 83d70378-011b-4ce3-e053-2991aa0a22be | 2026-06-23 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Cardinal Health 107, LLC | 65688bed-0d70-4b51-8301-1948b1deade1 | 2026-06-02 | Warnings, Adverse reactions | V92SO9WP2I |
| GLYCOPYRROLATE | GLYCOPYRROLATE | REMEDYREPACK INC. | 220cd5f5-3d71-4fdb-9943-7468799c179f | 2026-06-02 | Warnings, Adverse reactions | V92SO9WP2I |
| GLYCOPYRROLATE | GLYCOPYRROLATE | Golden State Medical Supply, Inc. | ec15e70c-8473-469a-9f07-ea668783fa07 | 2026-05-27 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Meitheal Pharmaceuticals Inc. | 02541cfd-b209-49b9-a73f-13ef18dce06d | 2026-05-20 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Par Health USA, LLC | ff65c5d3-7ba9-4315-a884-199151eb45a5 | 2026-05-14 | Warnings, Adverse reactions | V92SO9WP2I |
| GLYCOPYRROLATE | GLYCOPYRROLATE | Bryant Ranch Prepack | 098c7654-a352-47ee-bf23-6a81f8601266 | 2026-05-05 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Atlantic Biologicals Corp. | 50b493d7-8e3b-e459-e063-6394a90addbc | 2026-04-30 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Gland Pharma Limited | d670bd26-8a44-44be-90e1-107d4c380233 | 2026-04-28 | Warnings, Adverse reactions | V92SO9WP2I |
| glycopyrrolate | GLYCOPYRROLATE | Amneal Pharmaceuticals LLC | 741355f5-b695-41bb-a065-4abc687312b2 | 2026-04-28 | Warnings, Adverse reactions | V92SO9WP2I |
| BREZTRI | BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE | AstraZeneca Pharmaceuticals LP | 715433dc-cb2b-43ea-b6df-c5b4177adc6c | 2026-04-27 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Sagent Pharmaceuticals | 55930f87-8964-43b1-b790-c1e6dd2602d2 | 2026-04-20 | Warnings, Adverse reactions | V92SO9WP2I |
| GLYCOPYRROLATE | GLYCOPYRROLATE | Bryant Ranch Prepack | 21c7d201-c0b8-4f16-be4a-681d0b22791e | 2026-04-03 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate Oral Solution | GLYCOPYRROLATE ORAL SOLUTION | Sun Pharmaceutical Industries, Inc. | e20c9a89-2a81-3c6e-e053-2995a90a9861 | 2026-04-02 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Sandoz Inc | cb1ae370-ec4f-4114-9860-8f736f72b545 | 2026-04-01 | Warnings, Adverse reactions | V92SO9WP2I |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.